Clinical trials
Phase 1 Hyperglycemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Terminated | 3 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor Research Institute | 3 |
| Yale University | 3 |
| AstraZeneca | 2 |
| Duke University | 2 |
| Albert Einstein College of Medicine | 1 |
| Corcept Therapeutics | 1 |
| Emory University | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Hua Medicine Limited | 1 |
| Iowa State University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperglycemia | 24 |
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 1 | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Hypoglycemia | 5 |
| Glucose Intolerance | 2 |
| Insulin Resistance | 2 |
| Lymphoma | 2 |
| Metabolic Syndrome | 2 |
| ACTH Syndrome, Ectopic | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.